For clinicians, bladder stones (vesical calculi) are less a disease and more a symptom of a deeper problem, usually stasis or ...

As the researchers behind Pfizer and Astellas' Padcev and Merck's Keytruda have taken victory laps on the heels of the ...

The Food and Drug Administration approved Merck's Keytruda in combination with Astellas's Padcev to treat certain adults with muscle invasive bladder cancer (MIBC).

The FDA has approved Pfizer and Astellas’ Padcev (enfortumab vedotin-ejfv) plus Merck’s Keytruda (pembrolizumab) as a perioperative treatment for adults with muscle-invasive bladder cancer who are ...

• conservative treatment, which includes lifestyle changes (such as weight loss) and exercises such as pelvic floor muscle training to improve bladder control; • medications, which calm the bladder ...

A new bladder cancer treatment called TAR-200 has shown impressive results in a recent clinical trial. The study found that 82% of patients with high-risk non-muscle-invasive bladder cancer had their ...